by Five Rivers Rx | Aug 12, 2020 | Industry News, Regulations
The DSCSA has had wide-ranging implications on state regulation of the pharmaceutical supply chain. But are some states using it as an opportunity to increase their oversight which has resulted in onerous requirements for the industry? Background In early 2019,...
by Five Rivers Rx | Jul 30, 2020 | Industry News, Regulations
The patchwork that is state licensure is a constant challenge for all companies in the pharmaceutical supply chain – from international drug manufacturers to independent distributors. Companies not in compliance are at significant risk of being caught by state...
by Five Rivers Rx | May 20, 2020 | DEA, Industry News, Suspicious Order Monitoring
Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a valid prescription. The fine zeroes in on a common issue amongst...
by Five Rivers Rx | May 20, 2020 | Drug Manufacturers, Industry News
Even as the COVID-19 pandemic disrupts day-to-day life, the fight over drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are assessing significant fines to increase compliance. Fines in California & Nevada Over...
by Five Rivers Rx | May 6, 2020 | Industry News
Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two...
by Five Rivers Rx | May 6, 2020 | Industry News
In 2019, Minnesota announced an increase in registration fees for wholesalers and manufacturers from $235 per year to $5,260 (read more information here). The 2,200% increase for Minnesota fees has created an unprecedented barrier to entry for small wholesalers and...
